INTRODUCTION
Type 2 Diabetes Mellitus (T2DM) is a major public health problem and on increasing prevalence worldwide. To reduce the impact of T2DM, an action should be taken not only to treat the person with established diabetes mellitus but also to prevent the disease from occurring. T2DM is preceded by pre-diabetes for years before manifests as overt hyperglycemia. Pre-diabetes is also known for people who were diagnosed with impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG)¹. This group has increased risk of developing T2DM² and cardiovascular disease [3] [4] [5] . The development of IGT / IFG is due to the defects in the action and/or secretion of insulin. The primary prevention of diabetes mellitus is based on knowledge of the natural history of the development of IGT and risk factors. It is an important to identify an intervention targeted on individuals who are at highest risk of developing the disease 6 . Two reviews 2, 7 including fifth teen different populations from Europe, the United States of America, India, Africa and Pacific Island of Nauru reported an annual rate of developing diabetes in varied from 2 to 14 %. The risk was highest in those populations with the background of high prevalence of diabetes. Those with IFG had significantly increased a risk of mortality, which is related to cardiovascular disease. 8 Unwin and colleagues reported that IFG and IGT were strongly associated with CVD. IGT was strongly associated with CVD than IFG. 5 Every physician is looking for the efficient and effective interventions to prevent or delay the onset of diabetes mellitus. The type of interventions can be either pharmacological or non-pharmacological. The aim of this review is to establish the effective intervention in reducing the incidence of diabetes among people with pre-diabetes.
II. MATERIAL AND METHODS
Medline was searched via Pub Med, Google Scholar from 1970 to 2011 for randomized controlled trials (RCTs). A systematic review of the literatures was carried out to identify researches that focused on pharmacological or non-pharmacological interventions and to treat pre-diabetes as prevention of T2DM. The Medical Search Headings (MeSH) were used Type 2 Diabetes in Prevention, pre-diabetes, impaired glucose tolerance, and pharmacological or non-pharmacological interventions. Papers that focused on genetic, physiological and pathophysiological aspects will be excluded. All relevant titles and abstracts of the studies were reviewed. Study selections: In order to ensure the inclusion of high-quality evidence, only RCTs were selected in this review. Studies need to involve the administration of non-pharmacological and pharmacological interventions in delaying or preventing T2DM. All participants were those who were diagnosed with IGT. The pharmacological intervention was used drugs for the treatment of T2DM. The common oral diabetic agents such as Biguanides, Sulfonyureas and Alpha-glucosidase inhibitors are available in the government clinics. The outcome measure was the development of diabetes or oral glucose tolerance test (OGTT) monitoring. A total of 20 RCTs were selected in this systematic review.
III. RESULTS

Non Pharmacological Intervention
In this review a total of 12 RCTs were selected. The studies used non-pharmacological intervention i.e lifestyle modification to prevent T2DM (Table I ). All participants have had IGT and T2DM as an outcome measure. The non-pharmacological intervention always been targeted at altering the behavioral factors such as obesity, dietary intake and physical activity. In Uppsala, Sweden, Cederholm 9 had identified 53 people with glucose intolerance and randomized them to a diet and physical activity regimen or no advice or therapy. The results after six months showed the intervention group was 2.2 times more likely to have normal glucose tolerance than controls. There were significant, though small, decreases in glucose area under the OGTT curve, systolic blood pressure, cholesterol and triglycerides compared to the controls. Limitation of information on diet and physical activity suggested that even with short term intervention with weight loss and modest increase in physical activity may help normalize the glucose tolerance. Pan and colleagues 10 in Da Qing China had identified 530 people and randomized them by using the primary care clinic. The intervention encouraged lower simple sugars and less alcohol consumption, more vegetable intakes and weight loss from BMI ≥ 25 kg/m 2 to ≤ 23 kg/m 2 . Physical activity advice was aimed in increasing walking or running. Both interventions were conducted through individual and group sessions at a frequency, which weekly started and reduced to quarterly over the six year follow-up period. Compared to the control group who was given only limited written advice about diabetes and IGT. As a result, all the intervention groups had a significantly reduced incidence of diabetes over six years. This study gave a reasonable convincing data that lifestyle intervention can delay or prevent the diabetes.
A two-year randomized intervention conducted by Wing and colleagues 11 among overweight non diabetic subjects with family history of diabetes in which 72 of subjects had IGT at baseline. They were randomized to one of four interventions: control, diet, physical activity or both diet and physical activity. Throughout the period, total of participants dropped were only 27% in the last 18 months and weight regain occurred. The conclusion from this study was that, the three lifestyle approaches differed in the initial effectiveness but not in their long-term impact. However, the findings showed that modest weight loss in the entire group can reduce the incidence of diabetes is very important. The Finnish Diabetes Prevention Study 14, 15 was intended the intervention could delay or prevent type 2 and worsening of cardiovascular risk factors among people with IGT. The intervention decreased 5% of body weight or more and also reduced saturated fat intake to less than 30% of energy consumed, while increasing dietary fiber and physical activity. The control group only received limited annual diet and physical activity advice. Result showed that the lifestyle intervention reduced the incidence of diabetes by 58%. This study also proved that modest weight loss was achieved through dietary changes and increasing the activity can result in substantial reduction in diabetes incidence. The Diabetes Prevention Program (DPP) 16, 17 which involved 27 clinical centers and the participants were randomized into three intervention groups. The lifestyle intervention group was aimed to reduce body weight by 7% or more and increased moderate physical activity (usually brisk walking) to at least 150 minutes per week. The pharmacological group is discussed in the subsequent topic. Participants in lifestyle group lost an average of 5.6 kg of bodyweight compared to 0.1kg in the placebo group, and 74% met physical activity goal at the end of the core curriculum. The study concluded that the changes in dietary intake, increased activity and resulting weight loss will reduce of diabetes incidence even though the information to understand roles of the above changes on reduced diabetes incidence is not available. Most studies 12, 13, 18, 19, 20, 21, 22 have shown the benefits and impact of health and lifestyle changes in preventing the progression of IGT to T2DM.
Pharmacological Interventions Using Oral Anti-Diabetic Agent
Pharmacological interventions used hypoglycemic or anti-hyperglycemia agents. The rationale for drug intervention includes the following: 1) The drug may reverse one or more specific pathophysiological defects 2) Changes in lifestyle for healthy people are difficult to make even though they have demonstrated efficacy 3) Some other people are unable to change lifestyle due to disability or other diseases and it may be easier to take a drug over a longer period than take it significant behavioral change. Table II shows eight RCTs using pharmacological agent among impaired glucose tolerance specifically oral hypoglycemic or anti-diabetic agent. Papoz and colleagues conducted a randomized 22 , double blind trial among those who had borderline glucose tolerance (by current criteria, diagnosed as IGT) and tested for glucose and insulin levels for every six months for two years. There were 28% drop-outs and at two years, there were no significant differences in glucose or insulin levels. However, the case of worsening to diabetes was not reported. Other studies 23, 24 initiated with a small pilot study using Glicazide showed significantly reduction in fasting glucose, and this is led to The Fasting Hyperglycemia Study (FHS) at one year follow-up whereas the drug group showed significantly lower fasting glucose and HbA1c but no changes in control group. After six years only 188 subjects remained in the analysis, and only 3.2% in the glicazide developed overt diabetes than in control group 10.8% (p=0.047, ARR 7.6/100 person-years). Li and colleagues used low dose Metformin (250 mg tid) compared to placebo among subjects with IGT and results suggested that 50% reduction in diabetes incidence occurred after one year follow-up. DPP as the first large randomized study also showed that metformin will delay or prevent diabetes in high risk IGT subjects. Unfortunately long term duration of the metformin effect is unknown. The STOP-NIDDM also adds in the list of pharmacological intervention that reduces the incidence of diabetes. The IDDP 19 was the second large trial, the 3 year cumulative incidence of diabetes was significantly reduced to similar levels in all interventions (control =55% vs LSM=39%, MET=40.5%) and no additional effect of combining lifestyle and Metformin (LSM+MET=39.5%). (10) 
IV. TABLES
V. CONCLUSION
Discussion: This review focused on the evidence of non-pharmacological and pharmacological agents in preventing T2DM. Interventions work in some societies may not work in others because social, economic, and cultural forces influence diet and exercise. This is a special concern in our country, where there is great regional and ethnic diversity in lifestyle pattern and where diabetes is especially frequent in certain ethnicity. Primary prevention play an important role, since this review showed that intervention can reduce the risk of T2DM among people with impaired glucose tolerance, and lifestyle interventions seemed to be at least as effective as pharmacological interventions. Known risk factors, obesity and physical inactivity are strongly linked with the increase in the prevalence and incidence of T2DM. This means that lifestyle interventions that aim to reduce obesity and increase physical activity help to directly address these risk factors. Thus, there is an urgent needs for effective public health strategies to combat the rapid expansion of the diabetic population. Both nonpharmacological and pharmacological interventions had significantly reduced the risk of developing T2DM in people with IGT. However, examining the best approach of intervention, either non-pharmacological or pharmacological depends on many issues such as potential side effects, life-long course of medication and compliance. Strategies will be needed to assist compliance before implementation for both interventions. The above evidences will help in re-orientating existing health system of Diabetes Prevention Program in health clinics. CONCLUSION: In order to curb the rising diabetes epidemic, the prevention of T2DM is an urgent priority. The prevention of diabetes is a major challenge to global public health. A clinical trial done among IGT showed that a reduction in the progression of IGT to T2DM can be achieved by lifestyle changes 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22 . This intervention will be a real challenge to perform among high risk groups and populations. It is important to identify the high risk group such as IGT for diabetes prevention and to deliver lifestyle intervention. The use of pharmacological intervention such as Metformin and Acarbose can also prevent the progression of IGT to T2DM 19, 22, 23, 24, 25, 26, 27 All the above studies had found clearly support primary intervention for T2DM. No doubt all the clinical trials above showed that lifestyle modifications are considered the most effective means in delaying or preventing the development of T2DM. How to translate the finding of clinical research, into real world practice is a key issue to be addressed. The well trained staff are required in achieving the changing lifestyle among high risk group or participants in above studies/or this studies. We know that to achieve changes in lifestyle among those in high risk group or participants in above studies required strong efforts by well trained staff. Therefore, we need to carry out an effective lifestyle intervention program in a primary healthcare setting by using existing resources. It is better to do modest intervention that could produce beneficial effects on the incidence of T2DM over a period of time rather than vigorous intervention but only for
